United Therapeutics Corporation Variable Interest Entity, Measure of Activity, Income or Loss before Tax
United Therapeutics Corporation (UTHR) reported Variable Interest Entity, Measure of Activity, Income or Loss before Tax of $57.60 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-26.
Discontinued › Income Statement › Other Income
us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax · last filed 2020-02-26
- United Therapeutics Corporation variable interest entity, measure of activity, income or loss before tax for fiscal 2019 was $57.60M.
| Period end | Variable Interest Entity, Measure of Activity, Income or Loss before Tax 12 month |
|---|---|
| 2019-12-31 | $57.60M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |